Is it safe to take valbenazine with mirtazapine, duloxetine, trazodone, gabapentin, lorazepam, tizanidine, and methadone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safety Assessment of Valbenazine with Multiple Medications

Taking valbenazine with mirtazapine, duloxetine, trazodone, gabapentin, lorazepam, tizanidine, and methadone presents significant risk for excessive sedation, respiratory depression, and potential serotonin syndrome, requiring careful monitoring and possible dose adjustments.

Medication Interaction Analysis

Central Nervous System (CNS) Depression Risk

  • The combination of multiple CNS depressants creates a high-risk situation:

    • Lorazepam (benzodiazepine) - potent CNS depressant 1, 2
    • Tizanidine (muscle relaxant) - causes dose-dependent sedation 1
    • Methadone (opioid) - respiratory depressant
    • Mirtazapine - sedating antidepressant 3
    • Trazodone - commonly used for insomnia due to sedating properties 3
    • Gabapentin - can cause somnolence
  • The combined effect of these medications significantly increases the risk of excessive sedation, respiratory depression, and falls.

Serotonergic Burden

  • Multiple serotonergic agents increase serotonin syndrome risk:

    • Duloxetine (SNRI) - increases serotonin and norepinephrine 1
    • Mirtazapine - enhances serotonin transmission 3
    • Trazodone - serotonin reuptake inhibitor 3
    • Methadone - has some serotonergic properties
  • While tramadol-antidepressant combinations have been studied with caution advised but not contraindicated 4, this regimen contains multiple serotonergic agents, substantially increasing risk.

Specific High-Risk Combinations

  1. Duloxetine + Mirtazapine:

    • This combination (similar to "Limerick rocket fuel") can cause hypomanic switching and profound mental state alterations 5
    • Requires careful monitoring for mood changes
  2. Tizanidine + CNS Depressants:

    • Tizanidine should be used cautiously with other CNS depressants due to additive sedative effects 1
    • Recommended to take preoperatively but requires dose adjustment with multiple CNS depressants
  3. Lorazepam + Multiple Sedatives:

    • Benzodiazepines have additive effects with other CNS depressants 1
    • Increased risk of respiratory depression when combined with methadone

Monitoring Recommendations

  1. Respiratory Function:

    • Monitor for signs of respiratory depression, especially during sleep
    • Consider overnight pulse oximetry to detect nocturnal hypoxemia
  2. Mental Status:

    • Watch for excessive sedation, confusion, or delirium
    • Monitor for signs of serotonin syndrome: agitation, tremor, hyperthermia, hyperreflexia
  3. Cardiovascular Parameters:

    • Regular monitoring of blood pressure and pulse
    • Tizanidine can cause hypotension, especially when combined with other medications 1
  4. Fall Risk:

    • Implement fall precautions, especially in elderly patients
    • Consider mobility assessment

Risk Mitigation Strategies

  1. Dose Adjustments:

    • Consider reducing doses of sedating medications (particularly lorazepam, tizanidine, and trazodone)
    • Start with lower doses and titrate slowly
  2. Medication Timing:

    • Separate administration times of the most sedating medications
    • Consider taking trazodone and mirtazapine at bedtime only
  3. Medication Alternatives:

    • Evaluate if all medications are necessary
    • Consider alternatives with less sedating properties where possible
  4. Patient Education:

    • Advise against alcohol consumption
    • Warn about operating machinery or driving
    • Instruct on recognizing warning signs requiring medical attention

Conclusion

This medication combination carries significant risks of CNS depression and potential serotonergic effects. While not absolutely contraindicated, it requires careful monitoring, possible dose adjustments, and consideration of alternative regimens with fewer overlapping side effect profiles. The patient should be closely monitored for signs of excessive sedation, respiratory depression, and serotonin syndrome.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Other Antidepressants.

Handbook of experimental pharmacology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.